Busund LT - Search Results

1

Clinical significance of epidermal growth factor receptors in non-small cell lung cancer and a prognostic role for HER2 gene copy number in female patients.

Al-Saad S, Al-Shibli K, Donnem T, Andersen S, Bremnes RM, Busund LT. Al-Saad S, et al. Among authors: busund lt. J Thorac Oncol. 2010 Oct;5(10):1536-43. doi: 10.1097/JTO.0b013e3181ea510a. J Thorac Oncol. 2010. PMID: 20802349 Free article.

2

Inverse prognostic impact of angiogenic marker expression in tumor cells versus stromal cells in non small cell lung cancer.

Donnem T, Al-Saad S, Al-Shibli K, Delghandi MP, Persson M, Nilsen MN, Busund LT, Bremnes RM. Donnem T, et al. Among authors: busund lt. Clin Cancer Res. 2007 Nov 15;13(22 Pt 1):6649-57. doi: 10.1158/1078-0432.CCR-07-0414. Clin Cancer Res. 2007. PMID: 18006765

3

VEGF-A and VEGFR-3 correlate with nodal status in operable non-small cell lung cancer: inverse correlation between expression in tumor and stromal cells.

Donnem T, Al-Shibli K, Al-Saad S, Delghandi MP, Busund LT, Bremnes RM. Donnem T, et al. Among authors: busund lt. Lung Cancer. 2009 Feb;63(2):277-83. doi: 10.1016/j.lungcan.2008.05.022. Epub 2008 Jul 2. Lung Cancer. 2009. PMID: 18599153

4

Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer.

Al-Shibli KI, Donnem T, Al-Saad S, Persson M, Bremnes RM, Busund LT. Al-Shibli KI, et al. Among authors: busund lt. Clin Cancer Res. 2008 Aug 15;14(16):5220-7. doi: 10.1158/1078-0432.CCR-08-0133. Clin Cancer Res. 2008. PMID: 18698040

5

Prognostic impact of platelet-derived growth factors in non-small cell lung cancer tumor and stromal cells.

Donnem T, Al-Saad S, Al-Shibli K, Andersen S, Busund LT, Bremnes RM. Donnem T, et al. Among authors: busund lt. J Thorac Oncol. 2008 Sep;3(9):963-70. doi: 10.1097/JTO.0b013e3181834f52. J Thorac Oncol. 2008. PMID: 18758297 Free article.

6

Angiogenic markers show high prognostic impact on survival in marginally operable non-small cell lung cancer patients treated with adjuvant radiotherapy.

Andersen S, Donnem T, Al-Saad S, Al-Shibli K, Busund LT, Bremnes RM. Andersen S, et al. Among authors: busund lt. J Thorac Oncol. 2009 Apr;4(4):463-71. doi: 10.1097/JTO.0b013e3181991d18. J Thorac Oncol. 2009. PMID: 19204576 Free article.

7

Prognostic impact of fibroblast growth factor 2 in non-small cell lung cancer: coexpression with VEGFR-3 and PDGF-B predicts poor survival.

Donnem T, Al-Shibli K, Al-Saad S, Busund LT, Bremnes RM. Donnem T, et al. Among authors: busund lt. J Thorac Oncol. 2009 May;4(5):578-85. doi: 10.1097/JTO.0b013e31819f2e38. J Thorac Oncol. 2009. PMID: 19318994 Free article.

8

The prognostic value of intraepithelial and stromal innate immune system cells in non-small cell lung carcinoma.

Al-Shibli K, Al-Saad S, Donnem T, Persson M, Bremnes RM, Busund LT. Al-Shibli K, et al. Among authors: busund lt. Histopathology. 2009 Sep;55(3):301-12. doi: 10.1111/j.1365-2559.2009.03379.x. Histopathology. 2009. PMID: 19723145

9

Diverse prognostic roles of Akt isoforms, PTEN and PI3K in tumor epithelial cells and stromal compartment in non-small cell lung cancer.

Al-Saad S, Donnem T, Al-Shibli K, Persson M, Bremnes RM, Busund LT. Al-Saad S, et al. Among authors: busund lt. Anticancer Res. 2009 Oct;29(10):4175-83. Anticancer Res. 2009. PMID: 19846969 Free article.

10

The prognostic value of intraepithelial and stromal CD3-, CD117- and CD138-positive cells in non-small cell lung carcinoma.

Al-Shibli K, Al-Saad S, Andersen S, Donnem T, Bremnes RM, Busund LT. Al-Shibli K, et al. Among authors: busund lt. APMIS. 2010 May;118(5):371-82. doi: 10.1111/j.1600-0463.2010.02609.x. APMIS. 2010. PMID: 20477813

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

130 results

Search Page

Filters